nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.0429	0.0541	CcSEcCtD
Prochlorperazine—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.027	0.0341	CcSEcCtD
Prochlorperazine—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.0212	0.0268	CcSEcCtD
Prochlorperazine—Eruption—Furosemide—dilated cardiomyopathy	0.021	0.0265	CcSEcCtD
Prochlorperazine—Moricizine—SCN5A—dilated cardiomyopathy	0.0207	0.472	CrCbGaD
Prochlorperazine—Cholestasis—Furosemide—dilated cardiomyopathy	0.017	0.0215	CcSEcCtD
Prochlorperazine—Glycosuria—Furosemide—dilated cardiomyopathy	0.0159	0.0201	CcSEcCtD
Prochlorperazine—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.0151	0.0191	CcSEcCtD
Prochlorperazine—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.0148	0.0186	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.0147	0.0186	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.0137	0.0173	CcSEcCtD
Prochlorperazine—Throat sore—Lisinopril—dilated cardiomyopathy	0.0134	0.017	CcSEcCtD
Prochlorperazine—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.0133	0.0168	CcSEcCtD
Prochlorperazine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0133	0.0168	CcSEcCtD
Prochlorperazine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0124	0.0156	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.0121	0.0153	CcSEcCtD
Prochlorperazine—Trifluoperazine—TNNC1—dilated cardiomyopathy	0.0116	0.265	CrCbGaD
Prochlorperazine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.0113	0.0142	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.011	0.0139	CcSEcCtD
Prochlorperazine—Photosensitivity—Furosemide—dilated cardiomyopathy	0.0107	0.0135	CcSEcCtD
Prochlorperazine—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.0107	0.0134	CcSEcCtD
Prochlorperazine—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.0104	0.0131	CcSEcCtD
Prochlorperazine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00998	0.0126	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00994	0.0125	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00969	0.0122	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00969	0.0122	CcSEcCtD
Prochlorperazine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00929	0.0117	CcSEcCtD
Prochlorperazine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00892	0.0113	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00847	0.0107	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00829	0.0105	CcSEcCtD
Prochlorperazine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00802	0.0101	CcSEcCtD
Prochlorperazine—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00801	0.0101	CcSEcCtD
Prochlorperazine—Eczema—Lisinopril—dilated cardiomyopathy	0.00783	0.00988	CcSEcCtD
Prochlorperazine—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00779	0.00983	CcSEcCtD
Prochlorperazine—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00772	0.00975	CcSEcCtD
Prochlorperazine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00753	0.0095	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.0074	0.00933	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00731	0.00922	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00727	0.00917	CcSEcCtD
Prochlorperazine—Drowsiness—Furosemide—dilated cardiomyopathy	0.00723	0.00912	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00721	0.0091	CcSEcCtD
Prochlorperazine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00674	0.00851	CcSEcCtD
Prochlorperazine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00673	0.00849	CcSEcCtD
Prochlorperazine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0067	0.00845	CcSEcCtD
Prochlorperazine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00669	0.00844	CcSEcCtD
Prochlorperazine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00624	0.00788	CcSEcCtD
Prochlorperazine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00613	0.00774	CcSEcCtD
Prochlorperazine—Asthma—Lisinopril—dilated cardiomyopathy	0.00608	0.00767	CcSEcCtD
Prochlorperazine—Influenza—Lisinopril—dilated cardiomyopathy	0.00608	0.00767	CcSEcCtD
Prochlorperazine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00602	0.0076	CcSEcCtD
Prochlorperazine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00599	0.00756	CcSEcCtD
Prochlorperazine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.0058	0.00731	CcSEcCtD
Prochlorperazine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00578	0.00729	CcSEcCtD
Prochlorperazine—Erythema—Furosemide—dilated cardiomyopathy	0.00565	0.00713	CcSEcCtD
Prochlorperazine—Dizziness—Spironolactone—dilated cardiomyopathy	0.0056	0.00707	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.0056	0.00707	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00555	0.007	CcSEcCtD
Prochlorperazine—Weight increased—Lisinopril—dilated cardiomyopathy	0.00553	0.00698	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00549	0.00692	CcSEcCtD
Prochlorperazine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00543	0.00685	CcSEcCtD
Prochlorperazine—Rash—Spironolactone—dilated cardiomyopathy	0.00534	0.00674	CcSEcCtD
Prochlorperazine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00534	0.00673	CcSEcCtD
Prochlorperazine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00532	0.00672	CcSEcCtD
Prochlorperazine—Headache—Spironolactone—dilated cardiomyopathy	0.00531	0.0067	CcSEcCtD
Prochlorperazine—Jaundice—Lisinopril—dilated cardiomyopathy	0.00529	0.00667	CcSEcCtD
Prochlorperazine—Agitation—Furosemide—dilated cardiomyopathy	0.00519	0.00655	CcSEcCtD
Prochlorperazine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00506	0.00638	CcSEcCtD
Prochlorperazine—Leukopenia—Furosemide—dilated cardiomyopathy	0.00506	0.00638	CcSEcCtD
Prochlorperazine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.0048	0.00605	CcSEcCtD
Prochlorperazine—Dry mouth—Furosemide—dilated cardiomyopathy	0.0047	0.00593	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00461	0.00582	CcSEcCtD
Prochlorperazine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.0046	0.00581	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00451	0.00569	CcSEcCtD
Prochlorperazine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00448	0.00565	CcSEcCtD
Prochlorperazine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00435	0.00549	CcSEcCtD
Prochlorperazine—Hypotension—Furosemide—dilated cardiomyopathy	0.00431	0.00543	CcSEcCtD
Prochlorperazine—Erythema—Lisinopril—dilated cardiomyopathy	0.00424	0.00535	CcSEcCtD
Prochlorperazine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00412	0.00519	CcSEcCtD
Prochlorperazine—Somnolence—Furosemide—dilated cardiomyopathy	0.0041	0.00517	CcSEcCtD
Prochlorperazine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00407	0.00514	CcSEcCtD
Prochlorperazine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00399	0.00504	CcSEcCtD
Prochlorperazine—Tremor—Lisinopril—dilated cardiomyopathy	0.00397	0.00501	CcSEcCtD
Prochlorperazine—Constipation—Furosemide—dilated cardiomyopathy	0.00394	0.00497	CcSEcCtD
Prochlorperazine—Angioedema—Lisinopril—dilated cardiomyopathy	0.00387	0.00489	CcSEcCtD
Prochlorperazine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00379	0.00479	CcSEcCtD
Prochlorperazine—Cough—Lisinopril—dilated cardiomyopathy	0.0037	0.00467	CcSEcCtD
Prochlorperazine—Urticaria—Furosemide—dilated cardiomyopathy	0.00366	0.00462	CcSEcCtD
Prochlorperazine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00364	0.0046	CcSEcCtD
Prochlorperazine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00353	0.00445	CcSEcCtD
Prochlorperazine—Oedema—Lisinopril—dilated cardiomyopathy	0.00346	0.00436	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00346	0.00436	CcSEcCtD
Prochlorperazine—Infection—Lisinopril—dilated cardiomyopathy	0.00344	0.00433	CcSEcCtD
Prochlorperazine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.0034	0.00428	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00339	0.00427	CcSEcCtD
Prochlorperazine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00336	0.00424	CcSEcCtD
Prochlorperazine—Pruritus—Furosemide—dilated cardiomyopathy	0.00326	0.00411	CcSEcCtD
Prochlorperazine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00323	0.00408	CcSEcCtD
Prochlorperazine—Aripiprazole—ADRB1—dilated cardiomyopathy	0.00322	0.0733	CrCbGaD
Prochlorperazine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00313	0.00395	CcSEcCtD
Prochlorperazine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00308	0.00389	CcSEcCtD
Prochlorperazine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00307	0.00388	CcSEcCtD
Prochlorperazine—Dizziness—Furosemide—dilated cardiomyopathy	0.00305	0.00385	CcSEcCtD
Prochlorperazine—Constipation—Lisinopril—dilated cardiomyopathy	0.00296	0.00373	CcSEcCtD
Prochlorperazine—Rash—Furosemide—dilated cardiomyopathy	0.00291	0.00367	CcSEcCtD
Prochlorperazine—Dermatitis—Furosemide—dilated cardiomyopathy	0.0029	0.00366	CcSEcCtD
Prochlorperazine—Headache—Furosemide—dilated cardiomyopathy	0.00289	0.00364	CcSEcCtD
Prochlorperazine—Desipramine—SLC22A5—dilated cardiomyopathy	0.00277	0.063	CrCbGaD
Prochlorperazine—Urticaria—Lisinopril—dilated cardiomyopathy	0.00275	0.00347	CcSEcCtD
Prochlorperazine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00273	0.00345	CcSEcCtD
Prochlorperazine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00255	0.00321	CcSEcCtD
Prochlorperazine—Pruritus—Lisinopril—dilated cardiomyopathy	0.00245	0.00309	CcSEcCtD
Prochlorperazine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00229	0.00289	CcSEcCtD
Prochlorperazine—Rash—Lisinopril—dilated cardiomyopathy	0.00218	0.00275	CcSEcCtD
Prochlorperazine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00218	0.00275	CcSEcCtD
Prochlorperazine—Headache—Lisinopril—dilated cardiomyopathy	0.00217	0.00273	CcSEcCtD
Prochlorperazine—Loxapine—ADRB1—dilated cardiomyopathy	0.00206	0.0469	CrCbGaD
Prochlorperazine—Desipramine—ADRB1—dilated cardiomyopathy	0.00191	0.0435	CrCbGaD
Prochlorperazine—Desipramine—ADRB2—dilated cardiomyopathy	0.00161	0.0366	CrCbGaD
Prochlorperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000517	0.00316	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000516	0.00316	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000515	0.00315	CbGpPWpGaD
Prochlorperazine—DRD3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00051	0.00312	CbGpPWpGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000507	0.0031	CbGpPWpGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000507	0.0031	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000505	0.00309	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000505	0.00309	CbGpPWpGaD
Prochlorperazine—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.000503	0.00308	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000498	0.00305	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000498	0.00305	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00049	0.003	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00049	0.003	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00049	0.00299	CbGpPWpGaD
Prochlorperazine—DRD3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000484	0.00296	CbGpPWpGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000472	0.00289	CbGpPWpGaD
Prochlorperazine—HTR2C—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00047	0.00287	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00047	0.00287	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000463	0.00283	CbGpPWpGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000457	0.00279	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000456	0.00279	CbGpPWpGaD
Prochlorperazine—DRD2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000455	0.00279	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000455	0.00278	CbGpPWpGaD
Prochlorperazine—DRD3—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000451	0.00276	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000449	0.00274	CbGpPWpGaD
Prochlorperazine—HRH1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000447	0.00273	CbGpPWpGaD
Prochlorperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000442	0.0027	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000441	0.0027	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00044	0.00269	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000438	0.00268	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000438	0.00268	CbGpPWpGaD
Prochlorperazine—DRD2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000432	0.00264	CbGpPWpGaD
Prochlorperazine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000424	0.00259	CbGpPWpGaD
Prochlorperazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00042	0.00257	CbGpPWpGaD
Prochlorperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000419	0.00257	CbGpPWpGaD
Prochlorperazine—DRD2—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000418	0.00256	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000417	0.00255	CbGpPWpGaD
Prochlorperazine—HRH1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000407	0.00249	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000407	0.00249	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000394	0.00241	CbGpPWpGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00039	0.00239	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000388	0.00238	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000386	0.00236	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000386	0.00236	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000383	0.00234	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000379	0.00232	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000379	0.00232	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000377	0.00231	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000373	0.00228	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000373	0.00228	CbGpPWpGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00037	0.00226	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000368	0.00225	CbGpPWpGaD
Prochlorperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000364	0.00223	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000363	0.00222	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000359	0.0022	CbGpPWpGaD
Prochlorperazine—DRD3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000359	0.00219	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000358	0.00219	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000353	0.00216	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000348	0.00213	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000347	0.00212	CbGpPWpGaD
Prochlorperazine—DRD2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000345	0.00211	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000342	0.00209	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000337	0.00206	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000336	0.00206	CbGpPWpGaD
Prochlorperazine—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000334	0.00204	CbGpPWpGaD
Prochlorperazine—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000333	0.00204	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000319	0.00195	CbGpPWpGaD
Prochlorperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000311	0.0019	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000297	0.00182	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000292	0.00178	CbGpPWpGaD
Prochlorperazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000292	0.00178	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000287	0.00176	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000285	0.00175	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000285	0.00175	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000282	0.00172	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000277	0.00169	CbGpPWpGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000275	0.00168	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000273	0.00167	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000272	0.00167	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00027	0.00165	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000265	0.00162	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000265	0.00162	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000259	0.00159	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000259	0.00159	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000257	0.00157	CbGpPWpGaD
Prochlorperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000253	0.00155	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000247	0.00151	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000247	0.00151	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000241	0.00147	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000237	0.00145	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000233	0.00143	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00023	0.00141	CbGpPWpGaD
Prochlorperazine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000229	0.0014	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000225	0.00137	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000225	0.00137	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000223	0.00136	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000219	0.00134	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000218	0.00134	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000218	0.00134	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000218	0.00134	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000214	0.00131	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000214	0.00131	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000211	0.00129	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000211	0.00129	CbGpPWpGaD
Prochlorperazine—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00021	0.00128	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000209	0.00128	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000209	0.00128	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000208	0.00127	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000205	0.00126	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	0.000205	0.00126	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000203	0.00124	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000202	0.00124	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000202	0.00124	CbGpPWpGaD
Prochlorperazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.0002	0.00122	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000199	0.00122	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000199	0.00122	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000198	0.00121	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000198	0.00121	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000197	0.0012	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000196	0.0012	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000195	0.00119	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000195	0.00119	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000193	0.00118	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000192	0.00117	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000192	0.00117	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00019	0.00116	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00019	0.00116	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000189	0.00116	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	0.000186	0.00114	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000184	0.00113	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000181	0.00111	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000181	0.0011	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000179	0.00109	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000178	0.00109	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000175	0.00107	CbGpPWpGaD
Prochlorperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000173	0.00106	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000173	0.00106	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000173	0.00106	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000172	0.00105	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000168	0.00103	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000165	0.00101	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000164	0.001	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000162	0.000992	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000162	0.000989	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000159	0.000974	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000156	0.000957	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000154	0.000944	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000154	0.000941	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000153	0.000936	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000153	0.000936	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000152	0.000933	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00015	0.000916	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00015	0.000914	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000147	0.000901	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000147	0.000898	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000145	0.000885	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000143	0.000873	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000142	0.00087	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000142	0.000869	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00014	0.000858	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00014	0.000857	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00014	0.000855	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000138	0.000843	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000134	0.000821	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000134	0.000819	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000133	0.000812	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000133	0.000812	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000132	0.000807	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00013	0.000792	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000127	0.00078	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000127	0.000778	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000124	0.000756	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000123	0.000755	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000122	0.000744	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000121	0.000743	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.000121	0.000742	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00012	0.000731	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000119	0.000731	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000118	0.000723	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000118	0.00072	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000117	0.000716	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000117	0.000716	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000116	0.00071	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000115	0.000703	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000115	0.000703	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000114	0.000698	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000113	0.000692	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000113	0.000692	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000112	0.000687	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000112	0.000683	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00011	0.000674	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000109	0.000666	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000109	0.000664	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000107	0.000656	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000107	0.000654	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000105	0.000645	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000105	0.000644	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000105	0.000644	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000104	0.000634	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000104	0.000633	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000102	0.000624	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000102	0.000623	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.73e-05	0.000595	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.68e-05	0.000592	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.6e-05	0.000587	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.01e-05	0.000551	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.84e-05	0.000541	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.7e-05	0.000532	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—RAC1—dilated cardiomyopathy	8.67e-05	0.00053	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.55e-05	0.000523	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.44e-05	0.000516	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.39e-05	0.000513	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.32e-05	0.000509	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—AGT—dilated cardiomyopathy	8.28e-05	0.000507	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.26e-05	0.000505	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	7.52e-05	0.00046	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.45e-05	0.000455	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.34e-05	0.000449	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.31e-05	0.000447	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.21e-05	0.000441	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.19e-05	0.00044	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	7.18e-05	0.000439	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.09e-05	0.000434	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.67e-05	0.000408	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	6.63e-05	0.000406	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	6.51e-05	0.000398	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	6.41e-05	0.000392	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	6.34e-05	0.000388	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	6.22e-05	0.000381	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	6.12e-05	0.000375	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.79e-05	0.000354	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—RAF1—dilated cardiomyopathy	5.75e-05	0.000352	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.11e-05	0.000312	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	5.04e-05	0.000308	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.01e-05	0.000307	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	4.98e-05	0.000305	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.93e-05	0.000302	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	4.91e-05	0.0003	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	4.42e-05	0.00027	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	4.4e-05	0.000269	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	4.32e-05	0.000264	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	4.25e-05	0.00026	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—EGFR—dilated cardiomyopathy	3.94e-05	0.000241	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	3.42e-05	0.000209	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	3.3e-05	0.000202	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	3.21e-05	0.000196	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	3.02e-05	0.000185	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.96e-05	0.000181	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	2.91e-05	0.000178	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.89e-05	0.000177	CbGpPWpGaD
